(Updates with stock offering pricing details)
** Quotient Limited QTNT.O shares drop >20% premarket
after Switzerland-based diagnostics firm prices equity offering
** Co sells ~66.7 mln shares for $20 mln gross raise
urn:newsml:reuters.com:*:nGNX6ztBDb
** Offering prices at $0.30 vs stock's $0.40 last sale
** Co to use expected net offering proceeds of ~$18.5 mln to
fund ongoing development, commercialization of its MosaiQ blood
testing platform
** Jefferies and Cowen jt bookrunners for equity offering
** Early Fri, co posted fiscal Q4 rev of $9.8 mln, above
Street consensus of $8.2 mln, per Refinitiv IBES data, and said
sees FY 2023 rev of $39-$42 mln compared to $38.5 mln in FY 2022
urn:newsml:reuters.com:*:nGNX94bYqj
** Co has ~102.6 mln shares outstanding and ~77 mln shares
of public float, per Refinitiv
** QTNT has lost 85% YTD through Thurs close
** ~1.2 mln shares have exchanged hands before the bell vs
stock's 10-DMA volume of ~1.9 mln, per Refinitiv data
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-332-219-1430))